Literature DB >> 889300

Ocular dyskinesias in patients with Parkinson's disease treated with levodopa.

N Shimizu, B Cohen, S P Bala, M Mendoza, M D Yahr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 889300     DOI： 10.1002/ana.410010211

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  4 in total

1.  The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease.

Authors:  Sarah Lemieux; Mehrdad Ghassemi; Mandar Jog; Roderick Edwards; Christian Duval
Journal:  Exp Brain Res       Date:  2006-08-30       Impact factor: 1.972

2.  Ocular toxicity from systemic drug therapy. An overview of clinically important adverse reactions.

Authors:  S I Davidson; I G Rennie
Journal:  Med Toxicol       Date:  1986 May-Jun

3.  Ocular motor and manual tracking in Parkinson's disease and the effect of treatment.

Authors:  J M Gibson; R Pimlott; C Kennard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

4.  Case report: Blepharospasm in peak-dose dyskinesia may benefit from amantadine in Parkinson's disease.

Authors:  Qian-Ya Fan; Xiao-Dong Zhang; Ze-Di Hu; Shi-Shi Huang; Shi-Guo Zhu; Cai-Ping Chen; Xiong Zhang; Jian-Yong Wang
Journal:  Front Neurol       Date:  2022-09-30       Impact factor: 4.086
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.